This Tirzepatide research peptide guide covers purity verification, quality standards, and handling for GIP/GLP-1 research.
Tirzepatide is a dual-agonist peptide being studied for metabolic regulation. In plain terms, it activates two key hormone pathways (GLP-1 and GIP) that control appetite, blood sugar, and energy use. This makes it a central focus in weight management and metabolic syndrome research.
Research Compound · Tirzepatide
Tirzepatide Research Compound — Independently Verified.
Tirzepatide — investigational dual GIP/GLP-1 receptor co-agonist. The first dual incretin research compound to achieve FDA approval (Mounjaro/Zepbound). Studied for metabolic pathway research. 30mg lyophilized, HPLC verified.
COA included with every order For laboratory research use only
HPLC Verified≥98% purity confirmed per lot
COA IncludedLot-specific certificate ships with order
Mass Spec IDMolecular identity confirmed per batch
USA OperationsVerified sourcing. Documented chain.
About This Compound
What Is Tirzepatide?
Tirzepatide is a 39-amino-acid synthetic peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Developed by Eli Lilly, it received FDA approval as Mounjaro (type 2 diabetes) and Zepbound (obesity) — making it one of the few research peptides with a corresponding FDA-approved pharmaceutical counterpart.
In research settings, Tirzepatide is studied as a pharmacological tool for investigating dual incretin receptor pharmacology, the relative contributions of GIP vs GLP-1 agonism to metabolic outcomes, and adipose tissue regulation in preclinical models.
CoreVionRX doesn’t manufacture peptides. What we do — rigorously — is verify every batch before it reaches our catalog.
≥98%
Purity by Reversed-Phase HPLC
HPLC separates the compound from any impurities and measures the exact purity percentage. The chromatogram is documented on your COA.
MS/MS
Mass Spectrometry Identity Check
Electrospray ionization mass spectrometry verifies the molecular weight matches the compound specification. Confirms you’re getting the actual compound.
Lot #
Lot-Specific Certificate of Analysis
Your COA is tied to your specific production lot — not a generic document. This is not standard practice in this market. We made it one anyway.
100%
Documented Before Listing
No compound reaches our catalog without clearing our verification process first. If documentation isn’t available for a batch, that batch doesn’t ship.
Technical Specifications
Full Product Data
Everything you need to evaluate this compound for your research protocol.
Specification
Value
Compound
Tirzepatide
Class
Dual GIP/GLP-1 receptor co-agonist
Amino Acids
39
Drug Status
FDA-approved pharmaceutical (Mounjaro/Zepbound) — research compound sold separately
Form
Lyophilized powder
Vial Size
30mg per vial
Purity
≥98% by reversed-phase HPLC
Identity
Confirmed by electrospray ionization mass spectrometry
Storage (lyophilized)
−20°C, protected from light and moisture
Storage (reconstituted)
2–8°C, away from light
Documentation
Lot-specific COA with HPLC chromatogram — included with every order
Preclinical Research
What Researchers Study Tirzepatide For
All published research is preclinical — cell cultures and animal models. No human clinical trial data exists for Tirzepatide. Here’s where the science currently stands.
Dual Incretin Receptor Research
Tirzepatide is studied as a pharmacological tool for examining simultaneous GIP and GLP-1 receptor activation. Research investigates the relative contribution of each receptor subtype to insulin secretion, glucagon suppression, and gastric emptying.
Frías JP. et al. (2021) N Engl J Med 385(6):503-15
Metabolic Regulation Studies
Preclinical and clinical research has examined Tirzepatide’s effects on insulin secretion kinetics, hepatic glucose production, and glucagon regulation. The dual agonist mechanism produces effects distinct from either GIP or GLP-1 agonism alone.
Samms RJ. et al. (2021) Cell Metab 33(6):1123-35
Adipose Tissue Research
Research examines Tirzepatide’s effects on adipose tissue biology — including lipolysis, adipogenesis, and brown adipose tissue activation — to understand how dual GIP/GLP-1 agonism produces metabolic effects beyond glucose regulation alone.
Thomas MK. et al. (2021) J Clin Endocrinol Metab 106(2):388-96
Why CoreVionRX
Documentation Is the Product.
Most peptide vendors claim purity. We document it. Every compound ships with independent lab verification — not because regulations require it, but because you deserve to know exactly what you’re working with.
Independent HPLC Testing
Every batch runs through reversed-phase HPLC before we list it. The chromatogram appears on your COA. Verify the peak profile yourself.
Lot-Specific Documentation
Your COA is tied to your production lot — not a template document. “COA available upon request” is not how we operate.
Transparent About What We Are
We source and verify. We are not a synthesis lab. That honesty is deliberate — it’s the only way to build a brand worth buying from twice.
Lyophilized for Stability
Ships as lyophilized powder — stable at −20°C for 24+ months. Full integrity maintained until you’re ready to reconstitute.
Common Questions
Straight Answers.
What is Tirzepatide and how does it differ from GLP-1 agonists?
Tirzepatide is a 39-amino-acid dual agonist at both the GIP receptor and GLP-1 receptor. Most well-known GLP-1 agonists (semaglutide, liraglutide) act only at GLP-1R. Tirzepatide’s additional GIP receptor activity is the subject of active research to understand the differential contribution of each pathway to metabolic outcomes.
Is Tirzepatide the same as Mounjaro or Zepbound?
Tirzepatide is the active compound in Mounjaro (FDA-approved for T2D) and Zepbound (FDA-approved for obesity). The research compound sold by CoreVionRX is Tirzepatide as a raw research peptide — a separate form from the pharmaceutical drug. It is sold strictly for laboratory research use, not for human administration.
What research areas use Tirzepatide?
Research focuses on dual GIP/GLP-1 receptor pharmacology, comparative incretin biology, insulin secretion kinetics, hepatic glucose regulation, and adipose tissue biology. The availability of clinical data makes Tirzepatide particularly interesting for translational research.
How do I reconstitute Tirzepatide for research?
Reconstitute with bacteriostatic water. Given the 30mg vial, plan your target concentration based on your protocol volume needs. Inject water slowly down the vial wall, swirl gently. Use our reconstitution calculator for exact volumes.
How should Tirzepatide be stored?
Store lyophilized at −20°C, protected from light and moisture. After reconstitution, store at 2–8°C away from light. The 30mg format is suitable for lab settings requiring larger volumes across multiple experiments.
For laboratory research use only. Not for human or animal consumption. CoreVionRX supplies research compounds to qualified laboratories and research institutions.
Tirzepatide Research Peptide: What to Know Before You Buy
tirzepatide research peptide from CoreVionRX is verified at ≥99%% HPLC purity with mass spectrometry confirming the exact peptide sequence.
Every tirzepatide research peptide vial ships with HPLC verification and a lot-specific COA.
Every vial of tirzepatide research peptide ships with a lot-specific certificate of analysis so you can verify exactly what is in the vial you received.
CoreVionRX tirzepatide research peptide is verified by independent third-party testing — mass spectrometry confirms sequence identity and HPLC confirms purity.
Store tirzepatide research peptide as a lyophilized powder in cool, dark conditions; once reconstituted, keep refrigerated and use within your protocol window.
For accurate reconstitution of tirzepatide research peptide, use the peptide calculator to calculate the exact water volume needed.
Researchers working with tirzepatide research peptide should confirm ≥99%% HPLC purity and a lot-specific COA with every order.
For reconstitution, add bacteriostatic water slowly and store tirzepatide research peptide refrigerated after mixing. Use the peptide calculator to get concentration right.
When sourcing tirzepatide research peptide, the most important check is purity: every CoreVionRX vial is verified at ≥99% HPLC with a lot-specific COA.
Peer-reviewed research on tirzepatide research peptide is indexed at PubMed. For research use only.
All CoreVionRX research peptides ship with a lot-specific COA, ≥99%% HPLC purity, and mass-spec identity confirmation. Use our reconstitution calculator for prep. For research use only.
Sourcing verified tirzepatide research peptide is the first step in any reliable research protocol.
